Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.03.2026 FEUZ IE00B8X9NY41 1,959,822.00 EUR 114,845,089.67 58.600  ...

NEWPORT NEWS, Va.--(BUSINESS WIRE)--  NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) IN COMMON STOCK OF PAR VALUE $0.0001 EACH IN THE COMPANY (“Shares”) Awards made under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (“Omnibus Plan”) On March 12, 2026, the Company granted Performance Awards, Restricted Stock Unit Awards and Non-Qualified Stock Option Awards under the Omnibus Plan. Details of the vesting criteria and performance condi...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versus fulvestrant or everolimus plus exemestane, in people with hormone receptor (HR)-positive, human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (MBC) who had received prior cyclin-dependent kinase (CDK) 4/6 inhibitor-based treatment. The study met its prim...

NEWPORT NEWS, Va.--(BUSINESS WIRE)--NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) IN COMMON STOCK OF PAR VALUE $0.0001 EACH IN THE COMPANY (“Shares”) Awards made under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (“Omnibus Plan”) On March 12, 2026, the Company granted Performance Awards, Restricted Stock Unit Awards and Non-Qualified Stock Option Awards under the Omnibus Plan. Details of the vesting criteria and performance conditi...

SAVANNAH, Ga.--(BUSINESS WIRE)--Citi Trends, Inc. (NASDAQ: CTRN), a leading off-price value retailer of apparel, accessories and home trends primarily for Black families in the United States, today reported results for the fourth quarter and full year ended January 31, 2026. For purposes of comparison, unless otherwise stated, metrics in this release are compared to the 13-week quarter and 52-week full year ended February 1, 2025. Chief Executive Officer Comments Ken Seipel, Chief Executive Off...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 16.03.2026 RCTR.LN IE000J5PESP7 100,002.00 USD 1,958,180.97 19.582  ...

OXFORD, England & TOKYO--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate name Genesis Healthcare Co.), one of Japan’s leading genetic testing companies, today announce an international collaboration to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan. In its initial phase, the collabor...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 16.03.2026 MDEC.LN IE0007FIJUO5   50,002.00 USD   1,370,123.07   27.401  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 16.03.2026 FTEG.LN IE0009F7UB30  125,002.00 EUR   2,550,761.24   20.406  ...

GAND, Belgio, e TOKYO--(BUSINESS WIRE)--H.U. Group Holdings Inc., con la sua controllata al 100% Fujirebio Holdings, Inc. (d'ora innanzi denominata "Fujirebio"), oggi annuncia che Fujirebio Europe N.V. ha ottenuto una certificazione CE per il saggio ematico Lumipulse G NfL, in conformità al Regolamento (UE) 2017/746 sui dispositivi medici diagnostici in vitro (IVDR). Questo test CLEIA (dosaggio enzimatico immunologico a chemiluminescenza) permette di misurare quantitativamente la catena leggera...